- This event has passed.
The 2019 M&A Forum for Pharma, Biotech & Med Device
December 8, 2019 - December 11, 2019
December 9-11, 2019
Sheraton Philadelphia University City Hotel
3549 Chestnut St
Philadelphia, PA 19104
Innovative Partnership Opportunities for Product, Portfolio and Market Development
Offit Kurman Intellectual Property attorney, Gregory Grissett, will be speaking at The 2019 M&A Forum for Pharma, Biotech & Med Device. Creating innovative life sciences, pharma and biotech mergers and partnership opportunities has never been more critical to organizational growth. As product offerings grow, the industry is being impacted by rapidly changing market conditions, pricing considerations, and legislative updates. Don’t miss the opportunity to learn from and network with leaders in pharma, life sciences, and M&A.
Through a comprehensive agenda comprised of case studies and expert panels, you’ll gain timely insights into U.S. Anti-Trust Trends, what CFIUS could Mean for your M&A endeavor, due diligence best practices, and raising series funding. In addition, meet and network with essential industry stakeholders across both sides of the aisle, in a collaborative setting. Don’t miss this unique opportunity to gain best practices for developing your business strategy, while considering regulations.
ABOUT GREG GRISSET
firstname.lastname@example.org | 484.531.1713
Gregory Grissett helps businesses navigate complex intellectual property issues related to product development, marketing and capital investment, with experience spanning the apparel, textile, sporting goods, medical device, oil & gas, automotive, furniture, and consumer products industries. Gregory has a rare combination of experience in the international and business aspects of intellectual property (IP). He lived and worked in Paris, France, where he gained experience in U.S. and European patent procurement and enforcement. He also has business experience working with a major global materials corporation in IP management and licensing roles. Gregory's international perspective and practical experience help companies proactively manage IP development and enforcement issues unique to complex business operations.